Graham K. Cooper
2011 - Orexigen Therapeutics
In 2011, Graham K. Cooper earned a total compensation of $757.1K as Former Chief Financial Officer and Treasurer at Orexigen Therapeutics, a 30% decrease compared to previous year.
Compensation breakdown
| Option Awards | $408,151 |
|---|---|
| Salary | $68,436 |
| Other | $280,518 |
| Total | $757,105 |
Cooper received $408.2K in option awards, accounting for 54% of the total pay in 2011.
Cooper also received $68.4K in salary and $280.5K in other compensation.
Rankings
In 2011, Graham K. Cooper's compensation ranked 6,652nd out of 10,747 executives tracked by ExecPay. In other words, Cooper earned more than 38.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,652 out of 10,747 | 38th |
Division Manufacturing | 2,414 out of 3,960 | 39th |
Major group Chemicals And Allied Products | 568 out of 1,033 | 45th |
Industry group Drugs | 375 out of 781 | 52nd |
Industry Pharmaceutical Preparations | 298 out of 571 | 48th |
Source: SEC filing on April 27, 2012.
Cooper's colleagues
We found five more compensation records of executives who worked with Graham K. Cooper at Orexigen Therapeutics in 2011.
2011
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2011
Heather Turner
Orexigen Therapeutics
General Counsel
2011
Preston Klassen
Orexigen Therapeutics
Head of Global NB32 Program and Senior Vice President, Product Development
2011
Joseph Hagan
Orexigen Therapeutics
Chief Business Officer
2011
Mark Booth
Orexigen Therapeutics